ArticleClinical ophthalmology (Auckland, N.Z.)2021
Extraordinary Dynamic Near Vision in Champion Shotgun Shooters: PDI Check Evaluation of Stereo and Color without Floor Effect.
Article in Clinical ophthalmology (Auckland, N.Z.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04606355 (Autostereoscopic Dynamic Near Vision Testing of Acuity, Stereo and Color on PDI Check), which is not on this map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Autostereoscopic Dynamic Near Vision Testing of Acuity, Stereo and Color on PDI Check
Who cites it
6 citing papers in PubMed, 8 citations in OpenAlex.
- Impact of sports vision training on visuomotor skills and shooting performance in elite skeet shooters.Frontiers in human neuroscience · 2024Article
- Validation of the Affordable, Portable International Visionkeys System for Visual Acuity and Stereopsis.Clinical ophthalmology (Auckland, N.Z.) · 2024Article
- The impact of autostereoscopic screens on assessing depth perception.Annals of translational medicine · 2022Article
- A novel clinical dynamic stereopsis assessment based on autostereoscopic display system.Annals of translational medicine · 2022Article
- Pediatric Non-Refractive Vision Screening with EyeSwift, PDI Check and Blinq: Non-Refractive Vision Screening with Two Binocular Video Games and Birefringent Scanning.Clinical ophthalmology (Auckland, N.Z.) · 2022Article
- Trichromatic Enhanced Dynamic Color Screening on the PDI Check Nintendo 3DS Game.Clinical optometry · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundConventional near and stereo tests have a "floor effect;" inability to discriminate normal from super-normal. Shotgun champions require unique performance in binocularity and rapid color discrimination. PATIENTS AND
methodsTwenty-nine champion clay-target shooters, 14 normal Army and 12 color-normal subjects were tested with conventional near vision tests and on PDI-Check, a series of dynamic, near vision tests on the autostereoscopic Nintendo console.
resultsConventional tested shotgunners had all perfect Ishihara and 75% best 40 sec Stereo fly while Army had 92%perfect Ishihara and 69% best stereo fly. On PDI-Check, experienced shotgunners with median stereo of 17 (IQR 12-41) arc sec were better than Army volunteers 59 (IQR 30 to 487) arc seconds (Mann-Whitney U=62, p=0.04). Median PDI-Check for shotgun compared to Army was 88% compared to 84% for blue cone, 90% compared to 84% for green and 77% compared to 72% (red, Mann-Whitney p=0.05). Adding dark cherry filter shooting glasses improved the red and green color detection (p<0.01). This study lacked power to detect eye dominance using PDI Check color or stereo.
conclusionMany champion shotgun shooters had outstanding dynamic near stereo and better-than-average color vision which could be optimized with dark filter spectacles for red and green hues. PDI Check not only helps identify abnormal binocularity and color vision, but it can clarify supranormal vision as well.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.